ORAMED PHARMACEUTICALS INC (ORMP): Institutional Ownership
Hedge funds and institutional managers reporting a position in ORMP · Health Care. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.
Reported Holders
8
13F filers
Aggregate Value
$2.2M
Across holders
Last Price
$4.67
2026-06-26
Sector
Health Care
GICS
Holder activity5 new2 added1 reduced
| Manager⇅ | Type⇅ | Shares⇅ | Market Value▼ | % of Total⇅ | % of Portfolio⇅ | Action⇅ | QoQ Change⇅ | Quarter⇅ |
|---|---|---|---|---|---|---|---|---|
| MARSHALL WACE, LLP CIK 0001318757 | Hedge Fund | 260K | $883K | 39.8% | 0.0% | Added | +$126K | Q1 2026 |
| RENAISSANCE TECHNOLOGIES LLC CIK 0001037389 | Hedge Fund | 148K | $502K | 22.6% | 0.0% | Added | +$680 | Q1 2026 |
| BALYASNY ASSET MANAGEMENT LLC CIK 0001218710 | Hedge Fund | 17K | $209K | 9.4% | 0.0% | New | — | Q4 2022 |
| Hudson Bay Capital Management LP CIK 0001393825 | Hedge Fund | 52K | $176K | 7.9% | 0.0% | New | — | Q1 2026 |
| AQR CAPITAL MANAGEMENT LLC CIK 0001167557 | Hedge Fund | 18K | $155K | 7.0% | 0.0% | New | — | Q1 2022 |
| TWO SIGMA INVESTMENTS, LP CIK 0001179392 | Hedge Fund | 64K | $138K | 6.2% | 0.0% | New | — | Q1 2025 |
| Qube Research & Technologies Ltd CIK 0001729829 | Hedge Fund | 24K | $80K | 3.6% | 0.0% | New | — | Q1 2026 |
| CITADEL ADVISORS LLC CIK 0001423053 | Hedge Fund | 22K | $75K | 3.4% | 0.0% | Reduced | $-556K | Q1 2026 |
Added
Hedge Fund
$883K· 39.8% of total· 0.0% port· 260K sh· +$126K QoQ· Q1 2026
Added
Hedge Fund
$502K· 22.6% of total· 0.0% port· 148K sh· +$680 QoQ· Q1 2026
New
Hedge Fund
$209K· 9.4% of total· 0.0% port· 17K sh· — QoQ· Q4 2022
New
Hedge Fund
$176K· 7.9% of total· 0.0% port· 52K sh· — QoQ· Q1 2026
New
Hedge Fund
$155K· 7.0% of total· 0.0% port· 18K sh· — QoQ· Q1 2022
New
Hedge Fund
$138K· 6.2% of total· 0.0% port· 64K sh· — QoQ· Q1 2025
New
Hedge Fund
$80K· 3.6% of total· 0.0% port· 24K sh· — QoQ· Q1 2026
Reduced
Hedge Fund
$75K· 3.4% of total· 0.0% port· 22K sh· $-556K QoQ· Q1 2026